Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
KBA1412 / Kling Bio
NCT05501821: Study of KBA1412 in Participants With Advanced Solid Malignant Tumors	Completed	1	16	Europe	KBA1412, Pembrolizumab, Keytruda	Kling Biotherapeutics B.V.	Advanced Solid Tumor Malignancy	07/24	07/24